DK2522342T3 - Topisk formulering til behandling af hyperkeratonisk hud - Google Patents

Topisk formulering til behandling af hyperkeratonisk hud

Info

Publication number
DK2522342T3
DK2522342T3 DK12167943.5T DK12167943T DK2522342T3 DK 2522342 T3 DK2522342 T3 DK 2522342T3 DK 12167943 T DK12167943 T DK 12167943T DK 2522342 T3 DK2522342 T3 DK 2522342T3
Authority
DK
Denmark
Prior art keywords
hyperkeratonic
skin
treatment
topical formulation
topical
Prior art date
Application number
DK12167943.5T
Other languages
Danish (da)
English (en)
Inventor
Nilsson Johan Sundbom
Marie Lodén
Original Assignee
Auxilium Cura Innovatio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auxilium Cura Innovatio filed Critical Auxilium Cura Innovatio
Application granted granted Critical
Publication of DK2522342T3 publication Critical patent/DK2522342T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK12167943.5T 2011-05-12 2012-05-14 Topisk formulering til behandling af hyperkeratonisk hud DK2522342T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161485287P 2011-05-12 2011-05-12
EP11165916 2011-05-12

Publications (1)

Publication Number Publication Date
DK2522342T3 true DK2522342T3 (da) 2014-07-14

Family

ID=44317681

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12167943.5T DK2522342T3 (da) 2011-05-12 2012-05-14 Topisk formulering til behandling af hyperkeratonisk hud

Country Status (11)

Country Link
US (1) US9492407B2 (enExample)
EP (1) EP2522342B1 (enExample)
JP (1) JP6062928B2 (enExample)
CN (1) CN103717212B (enExample)
AU (1) AU2012254214B2 (enExample)
CA (1) CA2835874C (enExample)
DK (1) DK2522342T3 (enExample)
EA (1) EA024483B1 (enExample)
ES (1) ES2475840T3 (enExample)
WO (1) WO2012154122A2 (enExample)
ZA (1) ZA201308459B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105232357B (zh) * 2014-07-11 2020-06-26 杭州泽芙雪化妆品有限公司 一种用于治疗皮肤干燥症的保湿霜及其制备方法
CN105497186A (zh) * 2014-11-11 2016-04-20 于洁 一种治疗持久性豆状角化过度病的中药
US10092491B2 (en) * 2015-03-20 2018-10-09 John E. Kulesza Skin renewal enhancer
CN107308017A (zh) * 2016-04-26 2017-11-03 珠海宝德润生健康科技有限公司 一种具有祛痘功能的组合物及其制备方法
US12440432B2 (en) 2017-11-21 2025-10-14 Topix Pharmaceuticals, Inc. Methods and compositions for treatment of skin
CN108096111A (zh) * 2018-01-10 2018-06-01 广州市聚吉科绿色化学共性技术研究院有限公司 一种改善鸡皮肤组合物
SG11202009868TA (en) * 2018-05-15 2020-11-27 Essity Hygiene & Health Ab Fibrous product
JP7569059B2 (ja) * 2020-03-26 2024-10-17 ピアス株式会社 皮膚外用剤
CN111973478A (zh) * 2020-08-20 2020-11-24 广州博氏化妆品有限公司 一种足部护理液及其制备方法和使用方法
JP7751970B2 (ja) * 2020-12-15 2025-10-09 小林製薬株式会社 外用乳化組成物
EP4112039A1 (en) * 2021-07-01 2023-01-04 Unilever IP Holdings B.V. Cosmetic composition containing a polyol, an organic acid and a vitamin b5 compound
GB202302434D0 (en) * 2023-02-21 2023-04-05 Univ Of Reading Compositions and method for the treatment of onychomycosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE325667B (enExample) 1968-03-06 1970-07-06 Medisan Ab
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
US5776920A (en) * 1995-08-02 1998-07-07 Quarles; Ruth Method for treatment of psoriasis
CN1256124A (zh) * 1999-11-30 2000-06-14 韩国英 一种蛋白合成护肤剂
DE10133195A1 (de) * 2001-07-07 2003-01-16 Beiersdorf Ag Biotin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
WO2005016329A1 (en) * 2003-08-13 2005-02-24 Agis Industries (1983) Ltd. Topical compositions of urea and ammonium lactate
CA2639525A1 (en) * 2008-09-16 2010-03-16 Fayek Todary Michael Topical composition for the protection and/or treatment of radiation related skin damages

Also Published As

Publication number Publication date
WO2012154122A2 (en) 2012-11-15
EP2522342A1 (en) 2012-11-14
CN103717212A (zh) 2014-04-09
ZA201308459B (en) 2015-02-25
EA201391592A1 (ru) 2014-04-30
CA2835874A1 (en) 2012-11-15
CN103717212B (zh) 2016-06-29
EA024483B1 (ru) 2016-09-30
AU2012254214B2 (en) 2016-10-20
WO2012154122A3 (en) 2012-12-27
CA2835874C (en) 2019-08-06
JP6062928B2 (ja) 2017-01-18
EP2522342B1 (en) 2014-04-16
AU2012254214A2 (en) 2014-04-24
JP2014527024A (ja) 2014-10-09
US20140073613A1 (en) 2014-03-13
ES2475840T3 (es) 2014-07-11
US9492407B2 (en) 2016-11-15

Similar Documents

Publication Publication Date Title
LTPA2020510I1 (lt) Pakeistieji 4-fenil-piridinai, skirti su NK-receptoriumi susijusių ligų gydymui
DK2522342T3 (da) Topisk formulering til behandling af hyperkeratonisk hud
SMT201600271B (it) BENZOSSAZEPINONI FUSI COME MODULATORI DI CANALl IONICI
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
IL229474A0 (en) Cannabinoids for use in the treatment of neuropatich pain
DK2895156T3 (da) Fremgangsmåde til fremstilling af terapeutiske nanopartikler
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
HUE043171T2 (hu) Neurodegeneratív betegségek kezelésére hasznos 1-arilkarbonil-4-oxi-piperidinvegyületek
PL2744519T3 (pl) Kompozycje odmładzające do skóry
IL230844A0 (en) Combination treatments for hepatitis c
SI3513806T1 (sl) Sestava imunogena
EP2925325A4 (en) STABILIZED FORMULATION OF PEMETREXED
EP2790769A4 (en) ANTISEPTIC APPLICATOR
BR112014000015A2 (pt) formulação
EP2790770A4 (en) ANTISEPTIC APPLICATOR
EP2821053A4 (en) CLEANSING COMPOSITION FOR THE SKIN
EP2783256A4 (en) Therapeutic eyewear
IL229081A0 (en) Isoxazolines as therapeutic agents
HUE045947T2 (hu) Formuláció IBS kezelésére
HRP20181000T1 (hr) Postupci liječenja stanja povezanih s kosom
DK2705847T3 (da) Sammensætning til behandling af psoriasis
BR112014029487A2 (pt) método para o tratamento cosmético
DK2701707T3 (da) Fremgangsmåde til behandling af dyskinesi
EP2794550A4 (en) OPHTHALMIC FORMULATION
EP2770828A4 (en) FORMULATION